Key result
Treated HIV is linked to ~9% higher arterial stiffness and greater oxidative stress versus controls.
Why the study?
CVD prevalence is rising among PLWH in sub-Saharan Africa, but there is a paucity of data on vascular health and its relation to oxidative stress and endothelial activation in this population.
Are oxidative stress and endothelial activation associated with increased vascular stiffness among persons with treated HIV compared to HIV-negative controls?
Cross-Sectional (n=111)
No
Are oxidative stress and endothelial activation associated with increased vascular stiffness among persons with treated HIV compared to HIV-negative controls?
Treated HIV infection in sub-Saharan Africa is associated with greater oxidative stress and endothelial activation, which may contribute to increased arterial stiffness and cardiovascular disease risk.
May signal higher CVD risk in treated HIV; leaves open causal role of oxidative stress in sub-Saharan cohorts.
BACKGROUND: Cardiovascular disease (CVD) prevalence is rising among persons with HIV (PLWH) in sub-Saharan Africa. Oxidative stress and endothelial activation, resulting in reduced vascular compliance, are contributors to CVD risk. However, there is a paucity of vascular health data in this population. OBJECTIVES: To assess the relationships of oxidative stress and endothelial activation with vascular stiffness among PLWH. METHOD: Fifty-four PLWH on antiretroviral therapy > 5 years and 57 HIV-negative controls, all aged 18-45 years, were enrolled from the University Teaching Hospital, Lusaka, Zambia. Oxidative stress was measured by nitrotyrosine, a peroxynitrite biomarker, and endothelial activation by soluble intercellular adhesion molecule-1 (sICAM-1) plasma levels. Vascular compliance was measured using carotid-radial pulse wave velocity (crPWV) and arterial stiffness index (crASI). After adjusting for age, fat mass, and blood pressure, the estimated effect of a one unit increase in nitrotyrosine on crPWV were twofold higher in the PLWH, but neither reached significance. In a model pooling all participants, there were significant differences in the relationship of nitrotyrosine with crPWV and crASI by HIV status. CONCLUSION: PLWH in sub-Saharan Africa had significantly greater oxidative stress and endothelial activation compared to HIV-negative individuals. These factors may contribute to increased arterial stiffness and higher CVD prevalence in this population.
No takes yet. Share an insight, caveat, or question.
Chikopela et al. (2021) conducted a cross-sectional in HIV infection (n=111). HIV infection (treated) vs. HIV-negative controls was evaluated on carotid-radial arterial stiffness index (crASI) in cm/ms (p=0.048). Persons living with treated HIV in Zambia had a significantly higher carotid-radial arterial stiffness index (2.4 vs 2.2 cm/ms) and greater oxidative stress compared to HIV-negative controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: